KKR

KKR Sells 5.8% Stake in JB Chemicals & Pharmaceuticals for INR 1,460 Cr March 28, 2025 Global investment firm KKR has divested a 5.8% stake in JB Chemicals and Pharmaceuticals, raising INR 1,460 Cr through open market transactions. According to bulk deal data from the National Stock Exchange (NSE), KKR’s Tau Investment Holdings Pte, the promoter entity of JB Chemicals, offloaded 89.83 lakh shares in four separate transactions.

KKR to Acquire 54% Stake in Cancer Care Chain HCG for $400 Mn February 24, 2025 Private equity firm KKR to acquire a 54% stake in cancer care hospital chain HCG for $400 million, expanding oncology infrastructure in India.

KKR to Acquire 51% Stake in HCG from CVC Capital Partners February 14, 2025 Global investment firm KKR is set to acquire Healthcare Global Enterprises (HCG), a leading cancer care provider in India, strengthening its foothold in the country’s healthcare sector.

Uniting for Better Care: A Deep Dive into 2024’s Biggest Hospital M&As December 31, 2024 Explore the major mergers and acquisitions in the healthcare sector of 2024. Stay informed on key transactions, industry shifts, and their potential impact on the market.

KKR Set to Acquire HCG in Deal with CVC Capital December 5, 2024 KKR is in advanced talks to acquire Healthcare Global Enterprises Ltd (HCG), the largest specialty cancer care hospital chain in India, from CVC Capital Partners. The acquisition could lead to a delisting of HCG, with KKR set to drive expansion in non-metro areas.

KKR & GIC to Exit $3.2 Bn Stake in Metro Pacific Health September 26, 2024 KKR and GIC have appointed banks to oversee the sale of their 80% stake in Metro Pacific Health, the Philippines' largest private healthcare group. The deal could value the company at $3.2 billion.

Evolent Health Engages in Sale Talks With KKR, TPG & Others August 27, 2024 Private equity firms including TPG, Clayton, Dubilier & Rice (CD&R), and KKR are among those expressing interest in acquiring the healthcare software provider, which currently holds a market value of approximately $3.8 billion.

KKR, TPG, Alkem Labs Vie for Stent Maker SMT in INR 4000 Cr Deal August 20, 2024 SMT, which commands a 31% market share, had previously filed for an initial public offering (IPO) in 2021, aiming to raise INR 1,500 Cr, but the plan was subsequently put on hold.

Torrent Pharma Seeks to Raise $3 Bn to Buy KKR’s Stake in JB Chemicals August 14, 2024 Prominent financial institutions such as Barclays Plc, Deutsche Bank AG, and Standard Chartered Plc have been approached to facilitate the funding, according to the sources.

PE Titans General Atlantic, KKR, Others Battle for Majority Stake in Asian Institute of Medical Sciences July 30, 2024 The potential deal is expected to value the 1,200-bed chain serving North and East India at INR 1,500 Cr.

Infinx Healthcare Launches New R&D Center in Bengaluru July 15, 2024 Spanning 12,000 sq ft, this R&D center will focus on AI-driven product development, engineering, innovation, data science, and machine learning.

KKR to Acquire Kerala's Baby Memorial Hospitals for $300 Mn July 2, 2024 KKR & Co has planned to acquire a 70% controlling stake in Kerala's Baby Memorial Hospitals (BMH) for $300 million (INR 2500 Cr).